Murphy, Middleton, Hinkle & Parker, Inc. Eli Lilly & CO Transaction History

Murphy, Middleton, Hinkle & Parker, Inc.

$185 Million
Q3 2024

A detailed history of Murphy, Middleton, Hinkle & Parker, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Murphy, Middleton, Hinkle & Parker, Inc. holds 4,149 shares of LLY stock, worth $3.22 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares

4,149

Previous 4,272 2.88%

Holding current value

$3.22 Million

Previous $3.87 Million 4.97%

% of portfolio

1.98%

Previous 2.25%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $94,973 - $118,082	-123 Reduced 2.88%	4,149 $3.68 Million
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $20,296 - $25,453	-28 Reduced 0.65%	4,272 $3.87 Million
Q1 2024 Apr 11, 2024	SELL	$592.2 - $792.28 $23,688 - $31,691	-40 Reduced 0.92%	4,300 $3.35 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $75,102 - $88,535	143 Added 3.41%	4,340 $2.53 Million
Q3 2023 Oct 03, 2023	BUY	$434.7 - $599.3 $4,781 - $6,592	11 Added 0.26%	4,197 $2.25 Million
Q2 2023 Jul 05, 2023	BUY	$350.74 - $468.98 $350 - $468	1 Added 0.02%	4,186 $1.96 Million
Q1 2023 Apr 05, 2023	BUY	$310.63 - $364.82 $310 - $364	1 Added 0.02%	4,185 $1.44 Million
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $321 - $374	1 Added 0.02%	4,184 $1.53 Million
Q3 2022 Oct 07, 2022	SELL	$296.48 - $337.87 $5,336 - $6,081	-18 Reduced 0.43%	4,183 $1.35 Million
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $51,565 - $60,544	185 Added 4.61%	4,201 $1.36 Million
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $222,486 - $276,493	948 Added 30.9%	4,016 $1.15 Million
Q4 2021 Jan 13, 2022	SELL	$224.85 - $279.04 $13,041 - $16,184	-58 Reduced 1.86%	3,068 $847,000
Q3 2021 Oct 07, 2021	SELL	$221.6 - $272.71 $2,659 - $3,272	-12 Reduced 0.38%	3,126 $722,000
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $2,527 - $3,269	-14 Reduced 0.44%	3,138 $720,000
Q1 2021 Apr 08, 2021	SELL	$164.32 - $212.72 $13,474 - $17,443	-82 Reduced 2.54%	3,152 $589,000
Q4 2020 Jan 12, 2021	SELL	$130.46 - $172.63 $14,872 - $19,679	-114 Reduced 3.41%	3,234 $546,000
Q3 2020 Oct 13, 2020	SELL	$146.22 - $169.13 $96,212 - $111,287	-658 Reduced 16.43%	3,348 $496,000
Q2 2020 Jul 08, 2020	BUY	$136.42 - $164.18 $272 - $328	2 Added 0.05%	4,006 $658,000
Q1 2020 Apr 09, 2020	BUY	$119.05 - $147.35 $238 - $294	2 Added 0.05%	4,004 $555,000
Q4 2019 Jan 08, 2020	BUY	$106.92 - $132.43 $2,886 - $3,575	27 Added 0.68%	4,002 $526,000
Q1 2019 Apr 17, 2019	SELL	$111.31 - $131.02 $11,798 - $13,888	-106 Reduced 2.6%	3,975 $516,000
Q2 2018 Jul 13, 2018	BUY	$75.7 - $86.88 $308,931 - $354,557	4,081 New	4,081 $348,000

Others Institutions Holding LLY

# of Institutions

3,916

Shares Held

765M

Call Options Held

6.34M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $738B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy, Middleton, Hinkle & Parker, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Murphy, Middleton, Hinkle & Parker, Inc. with notifications on news.

Account

Murphy, Middleton, Hinkle & Parker, Inc. Eli Lilly & CO Transaction History